AlbionVC
AlbionVC is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at AlbionVC.
AlbionVC is a company.
Key people at AlbionVC.
AlbionVC is a leading UK-based venture capital firm that supports visionary founders in early-stage B2B software, healthcare, and deeptech companies with long-term capital and scale-up expertise.[1][2][4][5] Managing approximately £1 billion (with some sources citing up to $1.5 billion) in venture funds, it has invested in over 50 companies since 1996, backing four unicorns including Booking.com and Quantexa, and achieving a top-decile track record with multiple IPOs and exits.[2][4][5][6] Its investment philosophy emphasizes Series A opportunities in transformative technologies, leveraging 20+ years of sector expertise to drive impact in the UK startup ecosystem through hands-on operating support and connections to global networks.[1][3][5]
Founded in 1996 as the technology investment arm of Albion Capital Group LLP—a firm authorized and regulated by the Financial Conduct Authority—AlbionVC has evolved over nearly 30 years from general tech investments to a focused strategy on UK early-stage software, healthcare, and deeptech.[1][2][4][5][6] Key partners draw on collective experience totaling over 287 years, with a pivot toward high-impact areas like biotech spinouts from top universities and AI-driven innovations.[2][5][6] Pivotal moments include early backing of Europe's most successful startup, Booking.com, and recent expansions into university spinout funds targeting IP-rich assets from London's ecosystem, solidifying its role in producing category-defining companies.[2][5][6]
AlbionVC rides key trends in AI, deeptech, biotech, and digital assets, capitalizing on the UK's position as Europe's leader in crypto adoption (23 million users, 35% of adults) and its maturing ecosystem with £2.7bn in equity raised over the past decade.[3][5] Timing is ideal amid institutional capital inflows and regulatory clarity, enabling investments in efficiency boosters like Oriole Networks' light-based LLM training (100x faster, lower power) and precision therapies addressing unmet needs in epilepsy and ciliopathies.[2][5][6] It influences the ecosystem by bridging university spinouts to commercialization, fostering UK biotech hubs, and producing global players that shape decision intelligence (Quantexa), gene therapies, and sustainable tech, while advocating for durable company-building in high-growth phases.[2][5][6]
AlbionVC is poised to expand its third university spinout fund and deepen digital assets momentum, targeting more unicorns in AI, quantum, and genetic medicines amid UK's ecosystem inflection point.[5][6] Trends like rapid healthtech adoption via partnerships and energy-efficient deeptech will propel growth, potentially evolving its influence toward even stronger transatlantic ties with more NASDAQ listings. As partners to builders since 1996, AlbionVC exemplifies how focused expertise turns UK innovation into global scale.
Key people at AlbionVC.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 4, 2026 | Bound | $24.5M Series A | AlbionVC | 1818 Venture Capital, Album VC, GoHub Ventures, Moonfire Ventures, Norton, Notion Capital, Valar Ventures |
